A bispecific mRNA vaccine against zika and dengue viruses to overcome antibody-dependent enhancement and provide protection in preclinical models.
- DOI
- 10.1080/22221751.2026.2762582
- Published
- 2026 Nov 10
- Container
- Emerging microbes & infections
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/22221751.2026.2762582,
title = {A bispecific mRNA vaccine against zika and dengue viruses to overcome antibody-dependent enhancement and provide protection in preclinical models.},
author = {Shi H and Xie D and Jiang Y and Sun W and Sun P and Liang XJ and Ge XY and Huang Y},
year = {2026},
journal = {Emerging microbes \& infections},
doi = {10.1080/22221751.2026.2762582},
url = {https://doi.org/10.1080/22221751.2026.2762582}
}RIS
TY - JOUR TI - A bispecific mRNA vaccine against zika and dengue viruses to overcome antibody-dependent enhancement and provide protection in preclinical models. AU - Shi H AU - Xie D AU - Jiang Y AU - Sun W AU - Sun P AU - Liang XJ AU - Ge XY AU - Huang Y PY - 2026 JO - Emerging microbes & infections DO - 10.1080/22221751.2026.2762582 UR - https://doi.org/10.1080/22221751.2026.2762582 ER -
APA
H, S., D, X., Y, J., W, S., P, S., XJ, L., XY, G., & Y, H. (2026). A bispecific mRNA vaccine against zika and dengue viruses to overcome antibody-dependent enhancement and provide protection in preclinical models.. Emerging microbes & infections. https://doi.org/10.1080/22221751.2026.2762582
Source records
- pubmed · retrieved 2026-11-10T18:14:28.676Z